Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Fuji
Chinese Patent Office
Dow
Argus Health
Boehringer Ingelheim
Medtronic
McKinsey
Colorcon

Generated: October 22, 2017

DrugPatentWatch Database Preview

ENTECAVIR Drug Profile

« Back to Dashboard

What is the patent landscape for Entecavir, and when can generic versions of Entecavir launch?

Entecavir is a drug marketed by Aurobindo Pharma Ltd, Teva Pharms Usa, Accord Hlthcare, Hetero Labs Ltd V, Zydus Pharms Usa Inc, Amneal Pharms, Cipla Ltd, Sandoz Inc, Prinston Inc, and Par Pharm Inc. and is included in ten NDAs.

The generic ingredient in ENTECAVIR is entecavir. There are sixteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the entecavir profile page.

Summary for Tradename: ENTECAVIR

US Patents:0
Applicants:10
NDAs:10
Suppliers / Packagers: see list13
Bulk Api Vendors: see list64
Clinical Trials: see list159
Patent Applications: see list1,736
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ENTECAVIR at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
ENTECAVIR
entecavir
TABLET;ORAL206217-001Aug 26, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Prinston Inc
ENTECAVIR
entecavir
TABLET;ORAL208782-002Oct 10, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd V
ENTECAVIR
entecavir
TABLET;ORAL205740-001Aug 21, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
ENTECAVIR
entecavir
TABLET;ORAL202122-002Aug 26, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms
ENTECAVIR
entecavir
TABLET;ORAL206652-002Nov 12, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Par Pharm Inc
ENTECAVIR
entecavir
TABLET;ORAL206294-002Nov 23, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd V
ENTECAVIR
entecavir
TABLET;ORAL205740-002Aug 21, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Par Pharm Inc
ENTECAVIR
entecavir
TABLET;ORAL206294-001Nov 23, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz Inc
ENTECAVIR
entecavir
TABLET;ORAL206672-002May 11, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Cipla Ltd
ENTECAVIR
entecavir
TABLET;ORAL206872-002Dec 6, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Federal Trade Commission
US Army
Covington
Argus Health
UBS
Deloitte
McKinsey
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot